Search results
Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
Barrons.com· 12 hours agoSales of the drug were 9.4 billion Danish kroner ($1.4 billion), more than double the total from the...
Weight loss drug wins 25,000 new US users a week
BBC via Yahoo Finance· 12 hours agoThe surge reflects scorching demand for the medicine which, alongside sister diabetes drug Ozempic, has been hailed as revolutionary and helped to...
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
CNBC· 23 hours agoDanish pharmaceutical giant Novo Nordisk, which became the most valuable company in Europe last year...
Weight-loss drug maker Novo Nordisk's profits soar further
AFP via Yahoo Finance· 20 hours agoDanish pharmaceutical giant Novo Nordisk reported more soaring profits on Thursday thanks to the...
Europe’s AI Paradox: Slow Adoption, Big Ambitions
PYMNTS.com· 16 hours agoDespite Europe’s reputation as a tech laggard, a cadre of companies is making big bets on artificial intelligence (AI). While the region has been slow to...
Novo Nordisk, ING, Shell: European Stocks in the Spotlight
The Wall Street Journal· 13 hours ago↘️ **Novo Nordisk (DK: NOVO.B**, **NVO)**: Europe's most valuable company raised its annual guidance...
Europe’s Biggest Smart City Rises in Greece
Bloomberg via Yahoo Finance· 2 days ago...On the southern coastline of Greece’s capital, a long-awaited plan to transform the city’s former airport into the largest smart city in Europe is...
How Balkan gangsters became Europe’s top cocaine suppliers
Reuters· 18 hours agoIn 2018, convicted cocaine trafficker Slobodan Kostovski fled a Brazilian prison and made his way...
Geron (GERN) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 41 minutes agoLastly, from a patent and regulatory exclusivity perspective in the U.S., as shown at the end of the slide deck we are using today, we have orphan drug...
Novo Nordisk ups guidance buts cuts Wegovy price
Proactive Investors· 20 hours agoNovo Nordisk (NYSE:NVO), Europe's biggest company, said it is ramping up production of its diabtes/weightloss drugs Wegovy and Ozempic, after patient...
